Project Grant R01MH137160
Award Date
4/14/25
Completion Date
1/31/30
Dollars Obligated
$744K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21201, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $692,043 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to The Regents of the University of California, San Francisco (UCSF). The grant, awarded on December 18, 2024, will support research into the role of presynaptic homeostatic plasticity in mental health disorders such as autism and intellectual disability. The research aims to establish a mechanistic framework linking homeostatic plasticity to the genetic...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $742,484 to the University of Alabama at Birmingham (UAB) to conduct functional studies on a gene implicated in neurodevelopmental disorders such as autism, intellectual disability, and schizophrenia. The research will characterize a genetic mouse model to delineate the gene's function in the brain, including obtaining multiome single nucleus...
The National Institute of Mental Health (NIMH) awarded a $1,111,187 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Georgetown University. The grant, with a period of performance from July 15, 2024 to January 31, 2029, will support research to investigate how the chromatin remodeling protein CHD1 regulates synaptic homeostatic plasticity and its role in autism spectrum disorder (ASD) pathogenesis. The project aims to delineate the CHD1-dependent signaling network...
This $237,750 Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will support a research study conducted by the University of California, Merced. The study aims to elucidate the neurodevelopmental functions of the SMARCC2 gene and the Brahma Associated Factor (BAF) chromatin remodeling complex, which have been strongly implicated in autism spectrum disorders (ASD). Specifically, the research will investigate how...
This three-year, $3.456 million project grant from the National Institute of Mental Health (NIMH) Mental Health Research Grants program (CFDA 93.242) will fund research into the role of microglia in neurodevelopmental disorders. The grantee, Cold Spring Harbor Laboratory, will merge two-photon imaging of microglia and synapses in the brains of live mice with single-cell genomics and CRISPR screens. This will help define microglia's role in experience-dependent synaptic refinement, a process...
The National Institute of Mental Health (NIMH) awarded a 3-year, $413,681 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of Dayton Research Institute Division to conduct research on the role of phospholamban (PLN) in regulating the thalamic reticular nucleus (TRN), a brain region involved in sensory processing, attention, and sleep. The project will use transgenic mouse models, RNA sequencing, neurochemical analysis, and calcium imaging to investigate how PLN, a...
The National Institute of Mental Health (NIMH) awarded a $911,929 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the Scripps Research Institute in La Jolla, CA to conduct scalable functional analysis of neuropsychiatric risk genes using spatially integrated in vivo perturb-seq technology. This 5-year research project aims to comprehensively map the functions of 72 high-confidence autism spectrum disorder and neurodevelopmental delay (ASD/NDD) risk genes in the neocortex and...
The National Institute of Mental Health (NIMH) awarded a 5-year, $2,462,651 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Washington University in St. Louis. The grant will fund a systematic and scalable phenotyping effort to investigate the impact of prioritized genetic mutations known to cause neurodevelopmental and psychiatric disorders using over 100 mouse lines. Through behavioral analysis, anatomical mapping, and molecular assessments, the project...
This $731,035 Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, supports research to investigate the neural circuit dysfunction underlying auditory hallucinations in a mouse model of 22q11.2 deletion syndrome, a genetic disorder associated with a high risk of schizophrenia. The key objectives are to: 1) Test if mimicking 22q11.2 deletion abnormalities, such as reducing thalamic output and increasing...
The National Institute of Mental Health (NIMH) awarded a $234,000 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the Regents of the University of Michigan to study the impact of ectopic germline gene expression on neurodevelopmental disorders. The research aims to investigate whether the aberrant expression of germline-specific genes, typically only active in reproductive cells, contributes to the neurological complications observed in a mouse model lacking the chromatin...